S100A8/A9 (calprotectin) negatively regulates G2/M cell cycle progression and growth of squamous cell carcinoma.
Malignant transformation results in abnormal cell cycle regulation and uncontrolled growth in head and neck squamous cell carcinoma (HNSCC) and other cancers. S100A8/A9 (calprotectin) is a calcium-binding heterodimeric protein complex implicated in cell cycle regulation, but the specific mechanism a...
Main Authors: | Ali Khammanivong, Chengxing Wang, Brent S Sorenson, Karen F Ross, Mark C Herzberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3706396?pdf=render |
Similar Items
-
Evaluating Gene Expression, Purification and Structural Characterization of the Calprotectin Subunits of S100 A8and S100 A9
by: Hamideh Asghari, et al.
Published: (2014-06-01) -
S-Calprotectin (S100A8/S100A9): A Potential Marker of Inflammation in Patients with Psoriatic Arthritis
by: Claes Hansson, et al.
Published: (2014-01-01) -
The role of calprotectin (S100A8/A9) in the pathogenesis of glomerulonephritis and ANCA-associated vasculitis
by: Pepper, R. J.
Published: (2013) -
Regulation of S100A8/A9 (Calprotectin) Binding to Tumor Cells by
Zinc Ion and Its Implication for Apoptosis-Inducing Activity
by: Yuichi Nakatani, et al.
Published: (2005-01-01) -
Diagnostic Value of Fecal Calprotectin (S100 A8/A9) Test in Children with Chronic Abdominal Pain
by: Stanisław Pieczarkowski, et al.
Published: (2016-01-01)